Article
Alteration of Activator Protein 1 DNA Binding Activity in Gentamicin Induced Hair Cell Degeneration.
Search Medline for
Authors
Published: | December 6, 2005 |
---|
Outline
Abstract
Sensorineural hearing loss (SNHL) is associated with damage of cochlear hair cells (HCs) and/or of the neurons of the auditory pathway. This damage can result from a variety of causes, e.g. genetic disorders, aging, exposure to certain drugs such as aminoglycosides, infectious disease and intense sound overexposure. Intracellular events that mediate aspects of aminoglycoside mediated damage to HCs have been partially unraveled. Several independent research groups have demonstrated a crucial role of mitogen activated protein kinase (MAPK) signaling in aminoglycoside induced ototoxicity.
MAPKs are important mediators of signal transduction from the cell surface to the nucleus. Jun N-terminal kinases (JNK), members of the MAPK family, are strongly activated in cell culture conditions by stress-inducing stimuli. In HCs, the JNK signaling pathway was shown to be activated by aminoglycoside treatment. Activation of JNK leads to phosphorylation and thereby activation of transcription factors and consequently to altered gene expression.
One of the downstream targets of JNK is the transcription factor activating protein -1 (AP-1). AP-1 is a dimeric complex composed of members of the Fos and Jun proteins. Induction of AP-1 is thought to play a central role in reprogramming gene expression in response to external stimuli.
In this study we have analyzed the effect of gentamicin treatment on the downstream targets of JNK. Our results demonstrate that gentamicin treatment of explants of Organ of Corti (OC) results in increased AP-1 binding activity. The main component of these AP-1 complexes is the c-Fos protein. Moreover, we show that the AP-1 induction is transient and occurs exclusively in HCs of OC explants.